TÜBA Uluslararası Akademi Ödülleri 2017 Aday Gösterme Süreci Başladı TÜBA Başkanı Prof. Dr. Ahmet Cevat Acar’ın “23 Nisan Ulusal Egemenlik ve Çocuk Bayramı” Mesajı I. KAST ve TÜBA Ortak Sempozyumu “Kore ve Türkiye Arasında Bilimsel İş Birliği” Muhasebe Personeli İsmail Çolak Emekli Oldu TÜBA-Mikrobiyota ve İnsan Sağlığı Sempozyumu Gerçekleştirildi TÜBA-Kök Hücre ve Embriyo Uygulamaları Eğitim Sempozyumu Gerçekleştirildi TÜBA Asosye Üyesi Doç. Dr. Demirköz “Yükselen Yetenekler Ödülü”nü Aldı “Küresel Sağlığın İyileştirilmesi” Konulu “Science20 Dialogue Forumu” ve 2017 S20 Bildirisi TÜBA Başkan Yardımcısı Prof. Yurdusev EMAN Genel Kurulu’na Katıldı TÜBA-Mikrobiyota ve İnsan Sağlığı Sempozyumu
TÜBA Phase Studies and Ethical Rules Workshop on Clinical Studies was Held
Tarih: 19 OCAK 2017  Okunma Sayısı: 2220

TÜBA Phase Studies and Ethical Rules Workshop on Clinical Studies started on 13 January at The Green Park Hotel, Pendik and ended with the General Evaluation Meeting held on 14 January following the moderator presentations.

The workshop, which aims to contribute to the conduct of clinical trials in Turkey in accordance with the relevant rules, to increase the scientific impact of Turkey in the world, to develop the national pharmaceutical industry, to product biosimilar products and to increase the utilization rate of Turkey from international research funds, lasted two days.

12 different topics including patient and public awareness, studies conducted on animals, cellular therapy and regenerative medicine, ethical rules in studies conducted with biosimilar drugs, non-drug clinical studies were examined with the participation of around 200 scientists and administrators at the workshop. The Social Security Institution (SGK), the Ministry of Science, Industry and Technology, the Ministry of Health, the Turkish Medicines and Medical Devices Agency (TİTCK), universities as well as associations took part in the workshop.

Deputy Minister of Science, Industry and Technology Assoc. Prof. Hasan Ali Celik: "Science must be based on honesty and honesty."
Deputy Minister of Science, Industry and Technology Assoc. Prof. Hasan Ali Celik said the main aim of science, "search, find and discover something", is very enjoyable and voiced that it was very valuable to look for answers to the question "what, how, why?” in the opening speech of the workshop. Reminding that important studies have been carried out in order to make science sustainable for the benefit of humanity in our country, Çelik also said: "What kind of path will we take in the struggle that we give to the scientific achievement? This question, which is discussed at every turn, is quite complicated. Workshops, meetings, symposiums are being made and are being held all over the world like the workshop we have done to find answers. It should never be forgotten "science must rely on justice and honesty."

TÜBA President Prof. Acar: “A huge capital is turning at drugs and health sector.”

TÜBA President Prof. Ahmet Cevat Acar also stated that Turkey should be brought to an innovative level especially in the fields of medicine and health so as to be among the innovative economies.

Emphasizing the return of a huge capital, especially in drug and the health sector in general, Prof. Acar said: "Some global companies are able to enter into open and covered operations at the expense of violating the law, and of course we should not give a reason to our own temptation. It is obvious that such a commercialized area, which is the most basic and most natural human right, such as health, also has many drawbacks. Our workshop will provide important contributions to our country and humanity.”

Prof. Demirer "The workshop report will be an important reference source."
TÜBA Council Member and Cancer Working Group Leader Prof. Taner Demirer said "Thank you in advance for your contribution to the reports that will be prepared as a result of the workshop. This workshop, which is a collaboration of TÜBA Cancer Working Group and TÜBA Stem Cell Working Group, will prepare a very important report about the subject. This report will be an important reference for the Ministry of Health, the Ministry of Science, Industry and Technology, and scientists study in this area at the universities.

The studies lasted until late
The reports prepared by the scientist in the tables of "Pilot Studies, Phase I Studies and Bioavailability / Bioequivalence, Phase II Studies, Phase III Studies, Phase IV Studies, Retrospective Studies, Insurance of Scientific Studies and Evaluation of the Current Legislation, Code of Ethics in Nonclinical Clinical Investigations, Ethical Rules in Studies Made with Biosimilar Drugs, Cellular Therapy and Regenerative Medicine, Patient and Public Awareness, Ethical Rules on Studies on Animals as a result of discussions and studies lasted until late hours were announced by the moderators with presentations on January 14.

The conferences, "Phase Studies in Clinical Investigations and Problems in Our Country" by Prof. Taner Demirer, "Evaluation of the Results of the TİTCK Ethical Committees Workshop" by Clinical Research Department Head Nihan Burul Bozkurt and "Drug Investigations Made on Human Beings at Pharmaceutical Sector Perspective" by Representative of Investigative Drug Firms Association (AİFD) Hülya Demiral were also held at workshop.


06690 Çankaya - ANKARA
(312) 442 29 03 (pbx)
(312) 442 72 36 | 442 23 58 | 442 64 91
Bizden haber almak için e-posta adresinizi giriniz. Gönder
© 2013 TÜRKİYE BİLİMLER AKADEMİSİ. Her hakkı saklıdır.